A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 461 participants.
Also called NCT01958671
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 461 participants
- Sponsor
- Registry
-
NCT01958671 -
2013-002519-90
-
- Other papers using this trial's data
- Long-term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study
- Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01958671. Randomized; double masking; primary purpose treatment. Start 2013-10-09 (actual); primary completion 2016-07-28 (actual). Results posted on 2017-09-29.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Ertugliflozin 5 mg
- Intervention (Drug)
- Ertugliflozin 10 mg
- Intervention (Drug)
- Placebo to Ertugliflozin
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Placebo to Metformin
- Intervention (Drug)
- Glimepiride
- Lead sponsor
- Merck Sharp & Dohme LLC
- Collaborator
- Pfizer
Record details
- Record id
cardio:ct-nct01958671- Content hash
e3ce6c46ce0536959c530a5e7876ec5748eda1ae461f84b15e8c366d280bd408